Bemnifosbuvir and ruzasvir in combination exhibit potent synergistic antiviral activity in vitro while maintaining a favorable nonclinical safety profile in vivo.

bemnifosbuvir (AT-527) - Atea Pharma

ruzasvir (MK-8408) - Atea Pharma

http://www.ncbi.nlm.nih.gov/pubmed/40054502

Alex Vo; Jean-Pierre Sommadossi; Kai Lin; Nancy G B Agrawal; Shouqi Luo; Steven S Good

Mar 9, 2025